Accuray announces first patient treatment using CyberKnife M6 completed Accuray announced that the first patient treatment has been completed using the CyberKnife M6 System with the InCise Multileaf Collimator. The treatment was administered as a multidisciplinary effort between Dr. Steven Burton from the Department of Radiation Oncology and Dr. Johnathan Engh from the Department of Neurosurgery at UPMC in Pittsburgh, Pennsylvania. UPMC was one of the InCise MLC evaluation sites working in collaboration with Accuray.
Accuray says 16 hospitals in China awarded class A user licenses Accuray announced earlier today that class A user licenses for Accuray products were awarded to 16 hospitals during February by the Chinese National Health and Family Planning Commission. TomoTherapy System licenses were received by 12 hospitals and CyberKnife System licenses were received by four hospitals. Of the 16 licenses just issued, Accuray believes that six licenses will allow orders already in backlog to be recognized as revenue in the near future and 10 licenses are expected to lead to new system orders entered into backlog in the coming months. In total, between 2013 and year to date 2015, the NHFPC has released 32 of its planned 60 licenses.